이상반응 보고
| VAERS ID | 2073994 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | |
| 예방접종 횟수 | 2 |
| 접종일 | 2021-07-29 |
| 발병일 | 2021-09-11 |
| 상태 |
증상
- 초음파 스캔(Ultrasound scan)
- 자연 낙태(Abortion spontaneous)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
Test Name: Ultrasound scan; Result Unstructured Data: Test Result:Unknown
증상 상세
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from the Regulatory Authority.
Regulatory number: NL-LRB-00748925.
A 33-year-old female patient (pregnant) received bnt162b2 (COMIRNATY), administration date 29Jul2021 (Batch/Lot number: unknown) as dose 2, 0.
3 ml single for covid-19 immunisation.
The patient was 5 weeks pregnant at the time of exposure to bnt162b2.
The patient was 5 weeks pregnant at the event onset.
The patient's relevant medical history and concomitant medications were not reported.
Vaccination history included: Comirnaty (Dose 1, single, Lot number: unknown), administration date: 24Jun2021, for covid-19 immunisation, reaction(s): "Menstruation prolonged".
The following information was reported: ABORTION SPONTANEOUS (medically significant) with onset 11Sep2021, outcome "unknown", described as "Miscarriage".
The pregnancy resulted in spontaneous abortion.
The patient underwent the following laboratory tests and procedures: ultrasound scan: unknown.
Clinical course: Patient was at 5.
5 weeks.
She was not sure it was because of the vaccine.
But since patient menstruated for 3 weeks after vaccination, she thought the vaccines did something to her endometrium or hormones after all.
Patient had not previous covid-19 infection.
Diagnostic procedures included echo.
Sender Comment: Since the nature of the reported reaction does imply seriousness according to one of the criteria, the reaction was considered as serious by the Regulatory Authority.
No follow-up attempts are possible; information about lot/batch number cannot be obtained.
No further information is expected.
; Sender's Comments: Linked Report(s) : NL-PFIZER INC-202200085242 Same patient, 1st dose, different events.